首页> 美国卫生研究院文献>other >Accumulation of a Bioactive Benzoisochromanequinone Compound Kalafungin by a Wild Type Antitumor-Medermycin-Producing Streptomycete Strain
【2h】

Accumulation of a Bioactive Benzoisochromanequinone Compound Kalafungin by a Wild Type Antitumor-Medermycin-Producing Streptomycete Strain

机译:野生型生产抗肿瘤药-美德霉素的链霉菌菌株对生物活性苯并异苯并二氢醌化合物卡拉芬净的积累

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Medermycin and kalafungin, two antibacterial and antitumor antibiotics isolated from different streptomycetes, share an identical polyketide skeleton core. The present study reported the discovery of kalafungin in a medermycin-producing streptomycete strain for the first time. A mutant strain obtained through UV mutagenesis showed a 3-fold increase in the production of this antibiotic, compared to the wild type strain. Heterologous expression experiments suggested that its production was severely controlled by the gene cluster for medermycin biosynthesis. In all, these findings suggested that kalafungin and medermycin could be accumulated by the same streptomycete and share their biosynthetic pathway to some extent in this strain.
机译:从不同链霉菌中分离出来的两种抗菌和抗肿瘤抗生素美德霉素和卡拉芬净具有相同的聚酮化合物骨架核心。本研究首次报道了在产美德霉素的链霉菌菌株中发现了卡拉芬净。与野生型菌株相比,通过紫外线诱变获得的突变菌株显示这种抗生素的产量增加了3倍。异源表达实验表明,其产生受到美德霉素生物合成基因簇的严格控制。总体而言,这些发现表明,卡拉芬净和美德霉素可以在同一链霉菌中积累,并在该菌株中在一定程度上共享其生物合成途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号